Overview

Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants

Status:
Not yet recruiting
Trial end date:
2023-05-09
Target enrollment:
Participant gender:
Summary
This study will be conducted to compare the PK of salbutamol administered via metered dose inhalers (MDI) containing propellants 1,1-difluroethane (HFA-152a) and 1,1,1,2-tetrafluoroethane (HFA-134a) in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Albuterol
Norflurane